Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Karine
Karine Avril, Lyon FR
| Patent application number | Description | Published |
|---|---|---|
| 20110021849 | Process For The Preparation of Fluorinated Compounds - A subject-matter of the invention is a process for the preparation of 2,3,3,3-tetrafluoro-1-propene comprising the following stages: (i) hydrogenation of hexafluoropropylene to give 1,1,1,2,3,3-hexafluoropropane; (ii) dehydrofluorination of the 1,1,1,2,3,3-hexafluoropropane obtained in the preceding stage to give 1,2,3,3,3-pentafluoro- | 01-27-2011 |
Karine Bagramyan, North Hollywood, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090176259 | METHODS FOR DETECTION OF BOTULINUM NEUROTOXIN - Provided herein is a large immuno-sorbent surface area assay (ALISSA) for rapid and sensitive detection of toxin or enzyme activity. This assay is designed to capture a low number of toxin or enzyme molecules and to measure their intrinsic protease activity via conversion of a fluorigenic or luminescent substrate. The ALISSA is significantly faster and more sensitive than methods routinely utilized in the art. This assay is applicable for use for detection of a variety of toxins or enzymes having proteolytic activity, such as botulinum neurotoxin, | 07-09-2009 |
Karine Bernardeau, Coueron FR
| Patent application number | Description | Published |
|---|---|---|
| 20100197009 | Antibody or Fragment Thereof Recognizing AvitagTM and Uses Thereof - The application relates to antibodies which recognize the AviTag™ peptide of sequence MSGLNDIFEAQKIEWHE (SEQ ID No. 1) and to fragments thereof which recognize SEQ ID No. 1, wherein said antibodies or said fragments thereof recognize polypeptides containing SEQ ID No. 1 at their NH2 terminus and polypeptides containing SEQ ID No. 1 at their COOH terminus. The application further relates to a method for sorting target cells presenting on their surface a surface marker from a mixed cell population comprising the steps of: a) incubating said mixed cell population with a tagged adapter which binds to said surface marker of said target cells, wherein said adapter is bound to an antibody which recognizes said tag, and wherein said antibody is immobilized on a solid support. b) collecting said target cells. | 08-05-2010 |
Karine Broto, Rueil-Malmaison FR
| Patent application number | Description | Published |
|---|---|---|
| 20090010102 | METHOD FOR ADJUSTING A SEISMIC WAVE VELOCITY MODEL ACCORDING TO INFORMATION RECORDED IN WELLS - The invention is a method for defining the development conditions of a hydrocarbon reservoir by updating a velocity model by means of log data. A first seismic depth image representative of the reservoir is established by using seismic data and a velocity model. A series of log data is acquired from wells. Differences between seismic reflector depths observed in the first seismic depth image and depths for these reflectors identified in the wells are measured. The velocity model is modified to minimize these errors, using a prestack kinematic inversion technique allowing constraints to be taken into account. A new seismic depth image from which the development conditions of the hydrocarbon reservoir are determined is deduced therefrom. The invention has application for hydrocarbon reservoir development. | 01-08-2009 |
Karine Caumont-Bertrand, Frelinghien FR
| Patent application number | Description | Published |
|---|---|---|
| 20100120909 | COMPOSITION BASED ON SUBSTITUTED 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES, PREPARATION AND USES THEREOF - The invention concerns compositions comprising substituted 1,3-diphenylprop-2-en-1-one derivatives designed for therapeutic use. The inventive compositions are useful in particular for preventing or treating cardiovascular diseases, syndrome X, Ia restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms (benign or malignant tumors), neurodegenerative, dermatological diseases and disorders related to oxidative stress, for preventing or treating the effects of ageing in general and for example skin ageing, in particular in the field of cosmetics (occurrence of wrinkles and the like). | 05-13-2010 |
| 20100286276 | Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof - The present invention concerns substituted 1,3-diphenylpropane derivatives, pharmaceutical compositions comprising them and the therapeutic uses thereof, particularly in the field of human and animal health. | 11-11-2010 |
| 20110136888 | Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof - The present invention involves substituted 1,3-diphenylpropane derivatives, pharmaceutical compositions comprising them and the therapeutic uses thereof, in particular in the fields of human and animal health. | 06-09-2011 |
| 20110190515 | SUBSTITUTED 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES, PREPARATION AND USES THEREOF - The invention concerns novel substituted 1,3-diphenylprop-2-en-1-one derivatives, pharmaceutical compositions comprising same, their therapeutic uses, in particular for treating cerebral ischemia. The invention also concerns a method for preparing said derivatives. | 08-04-2011 |
Karine Caumont-Bertrand, Freilinghein FR
| Patent application number | Description | Published |
|---|---|---|
| 20110195993 | PPAR AGONIST COMPOUNDS, PREPARATION AND USES - The present invention relates to novel PPAR agonist compounds as well as pharmaceutical compositions containing them. | 08-11-2011 |
Karine Chandes, Villeurbanne FR
| Patent application number | Description | Published |
|---|---|---|
| 20100269775 | SIX-STROKE INTERNAL COMBUSTION ENGINE, METHOD OF OPERATION OF SUCH AN ENGINE AND VEHICLE EQUIPPED WITH SUCH AN ENGINE - A six-stroke internal combustion engine is provided with an injection arrangement adapted to inject into at least one of its cylinders a liquid containing a reductor agent and/or a precursor for a reductor agent. During the fifth and sixth strokes of a piston within the cylinder, this reductor agent can react with NOx molecules in order to clean the gases resulting from the combustion of a fuel mixture within the cylinder. | 10-28-2010 |
Karine Chemin, Venissieux FR
| Patent application number | Description | Published |
|---|---|---|
| 20110212110 | Compositions and Methods for Detecting TLR3 - The present invention relates to antibodies, antibody fragments, and derivatives thereof that specifically bind to TLR3 cell receptors present on the surface of cells. The invention also relates to hybridomas producing such antibodies; methods of making such antibodies; fragments, variants, and derivatives of the antibodies; pharmaceutical compositions comprising the same; methods of using the antibodies to detect TLR3 levels on the surface of cells, and the use of such antibodies and compositions for diagnostic or therapeutic purposes in subjects. | 09-01-2011 |
Karine Clément, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110113863 | MEANS AND METHODS DIAGNOSING GASTRIC BYPASS AND CONDITIONS RELATED THERETO - The present invention relates to the field of diagnostic measures. Specifically, it contemplates a method for assessing whether gastric bypass therapy was successful in a subject, a method of predicting whether gastric bypass therapy will be beneficial for a subject in need thereof, and a method of diagnosing whether a supportive therapy accompanying gastric bypass has beneficial effects on a subject in need thereof. Further provided are diagnostic methods for diabetes and body lean mass. Furthermore, the invention relates to a method for identifying a treatment against diabetes and/or obesity. | 05-19-2011 |
Karine Corcelle, Kembs FR
| Patent application number | Description | Published |
|---|---|---|
| 20120122866 | TOPICAL PHARMACEUTICAL COMPOSITION INCLUDING REL-N-[6-[(2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL]-3-PYRIDINYL]-2-METHYL-4'-(T- RIFLUOROMETHOXY)-[1,1'-BIPHENYL]-3-CARBOXAMIDE - The present invention relates to pharmaceutical compositions of 2-Methyl-4′-trifluoromethoxy-biphenyl-3-carboxylic acid [6-(cis-2,6-dimethyl-morpholin-4-yl)-pyridin-3-yl]-amide, to the use of such compositions in therapeutic applications and to methods for manufacturing such compositions. | 05-17-2012 |
Karine Courbeyrette, Massy FR
| Patent application number | Description | Published |
|---|---|---|
| 20100297168 | LENTIVIRAL GENE TRANSFER VECTORS AND THEIR MEDICINAL APPLICATIONS - The present invention relates to the design of gene transfer vectors and especially provides lentiviral gene transfer vectors suitable for either a unique administration or, for iterative administration in a host, and to their medicinal application (such as vaccination against Immunodeficiency Virus, especially suitable in human hosts). Gene transfer vectors are either integrative or non-integrative (NI) vectors, dependently upon the purpose of their use. The invention relates to the use of gene transfer vectors for unique or for multiple in vivo administration into a host in need thereof. The field of application of the present application concerns in particular animal treatment or treatment of human being (e.g. prophylactic or therapeutic or symptomatic or curative treatment), gene therapy or vaccination in vivo. These vectors may be used to elicit an immune response to prevent or to treat a pathogenic state, including virus infections (for example treatment or prevention against Immunodeficiency Virus and especially against AIDS), parasite and bacterial infections or cancers, and preferably to elicit a protective, long-lasting immune response. | 11-25-2010 |
Karine Darriet, Creon FR
| Patent application number | Description | Published |
|---|---|---|
| 20100152477 | HETEROGENEOUS ORGANOTIN CATALYSTS - Supported heterogeneous organotin catalysts of the formula X1, X2, or X3: | 06-17-2010 |
| 20100174106 | HETEROGENEOUS ORGANOTIN CATALYSTS - Supported heterogeneous organotin catalysts of the formula X1, X2, or X3: | 07-08-2010 |
Karine De Bono, Marseille FR
| Patent application number | Description | Published |
|---|---|---|
| 20100235019 | METHOD OF DETERMINING AND DISPLAYING FLYING INDICATIONS AND A FLIGHT INDICATOR FOR IMPLEMENTING SAID METHOD - The present invention relates to a pilot assistance method for giving assistance in piloting a rotary wing aircraft, the method consisting in using a scale with collective pitch graduations that is movable on a display screen to indicate the position of the collective pitch, in determining the desynchronization pitch, in using a maximum limit value and a minimum limit value for the speed of rotation of the rotor, in transforming the maximum limit value and the minimum limit value in real time and as a function of physical flight parameters respectively into a bottom limit position and a top limit position for the collective pitch, and when a determined difference appears between the real value and the reference value Nr0 for the speed of rotation of the rotor, in displaying at least one item of corrective information about the adjustment of the collective pitch. | 09-16-2010 |
Karine Deffez, Lyon FR
| Patent application number | Description | Published |
|---|---|---|
| 20110046193 | DEFERACIROX DISPERSIBLE TABLETS - The invention pertains to dispersible tablets comprising as active ingredient 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid or pharmaceutically acceptable salt thereof in an amount of from 5 to 40% in weight by weight of the total tablet. | 02-24-2011 |
| 20110319457 | DEFERACIROX DISPERSIBLE TABLETS - The invention pertains to dispersible tablets comprising as active ingredient 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid or pharmaceutically acceptable salt thereof in an amount of from 5 to 40% in weight by weight of the total tablet. | 12-29-2011 |
Karine Descroix, Saint-Colomban FR
| Patent application number | Description | Published |
|---|---|---|
| 20100286388 | USE OF MODIFIED OLIGO-B-(1,3)-GLUCANS FOR TREATING DISEASES OF THE IMMUNE SYSTEM, OLIGO-B- (1,3V-GLUCAN-(1,3)- MANNOSE, OLIGO-B-(1,3)-GLUCAN-(1,3)- MANNITOL AND DERIVATIVES THEREOF, METHODS FOR PREPARING THEM AND MEDICAMENTS CONTAINING THEM - The present invention relates to the use of at least one compound of formula (I) or (II), in which R | 11-11-2010 |
| 20110086767 | MUTANTS OF GLYCOSIDE HYDROLASES AND USES THEREOF FOR SYNTHESIZING COMPLEX OLIGOSACCHARIDES AND DISACCHARIDE INTERMEDIATES - Method for preparing the disaccharide α-D-glucopyranosyl-(1→4)-2-N-acetyl-2-deoxy-α-D-glucopyranoside, comprising the step of using a mutant of a wild type glycoside hydrolase. | 04-14-2011 |
Karine Djandjougazian, Dopenhagen DK
| Patent application number | Description | Published |
|---|---|---|
| 20090029457 | PHARMACEUTICAL COMPOSITION FOR INDUCING AN IMMUNE RESPONSE IN A HUMAN OR ANIMAL - The present invention relates to a pharmaceutical composition for inducing an immune response in a human or animal, comprising dendritic cells loaded with at least five cancer/testis antigen and no lineage specific differentiation antigens or substantially no lineage specific differentiation antigens provided from at least one cancer cell line, as well as to isolated cell lines expressing a multiplicity of cancer testis antigens and no differentiation antigens, and to a method of inducing an immune response in a human or animal using the composition of the invention. | 01-29-2009 |
Karine Djandjougazian, Copenhagen DK
| Patent application number | Description | Published |
|---|---|---|
| 20090196856 | Method for Generating Dendritic Cells Employing Decreased Temperature - The invention relates in certain embodiments to a method for generating dendritic cells by employing temperatures below 37° C. during the development of progenitor cells and immature dendritic cells. In some embodiments the invention relates to populations of dendritic cells and its use. | 08-06-2009 |
Karine Dzhandzhugazyan, Copenhagen DK
| Patent application number | Description | Published |
|---|---|---|
| 20100092498 | Anti-Tumour Vaccine Derived from Normal Chemically Modified Cells - A composition for inducing an immune response in a mammal, comprises lymphoid cells in which expression of tumor antigens has been chemically induced. The tumor antigens are induced in proliferating normal lymphoid cells, especially during the log phase of proliferation. The proliferation of the normal lymphoid cells is stimulated by normal mature dendritic cells. Most conveniently, the lymphoid cells are lymphocytes, especially peripheral blood lymphocytes. The tumor antigens are typically cancer/testis antigens, which may be chemically induced by DNA demethylation. Cancer/testis antigens are expressed in a wide range of tumors, so the composition is able to raise an immune response that is effective against a wide range of tumors, despite the fact that it is derived from normal cells. The composition may be used for preparation of an anti-tumor vaccine for prophylactic or therapeutic use. The composition may also be used for ex vivo activation of cytotoxic T lymphocytes, followed by expansion of the cytotoxic T lymphocyte population by normal dendritic cells, for cancer treatment by adoptive T cell immunotherapy. | 04-15-2010 |
Karine Excoffier, Montbonnot FR
| Patent application number | Description | Published |
|---|---|---|
| 20090019515 | METHOD AND SYSTEM FOR SECURE ACCESS POLICY MIGRATION - A method for deploying a directory server that includes receiving a new version of the directory server on a server to replace a prior version of the directory server, wherein the new version of the directory server uses a new version of an access policy and the prior directory server uses a prior version of the access policy, and configuring the new version of the directory server to use both the prior version of access policy and the new version of the access policy, wherein the new version of the directory server maintains compatibility between the new version of the access policy and the prior version of the access policy. | 01-15-2009 |
Karine Fabio, Bethlehem, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20120010168 | Unique Dual-Action Therapeutics - A new family of therapeutics which provides a controlled-release delivery platform for non-steroidal anti-inflammatory agents on an ester or an ester-carbonate backbone is disclosed herein. These agents are reversible inhibitors of acetylcholinesterase and are thus useful for clinical conditions benefiting from inflammation suppression and cholinergic intervention. These compounds are of the general formula wherein n=0, 1; X═C, Si, and N+ and NSAID=ibuprofen, naproxen, indomethacin and diclofenac. Other embodiments are also disclosed. | 01-12-2012 |
Karine Gallerne, Linas FR
| Patent application number | Description | Published |
|---|---|---|
| 20110124391 | Scratch-card game system and corresponding game medium - The game system is characterized in that it comprises a first instant game based on the purchase by a player of a game medium ( | 05-26-2011 |
Karine Goraj, Rixensart BE
| Patent application number | Description | Published |
|---|---|---|
| 20110311577 | METHOD OF PRODUCING A VACCINE - The present invention relates to a method for purifying bacterial cytolysins such as pneumococcal pneumolysin. A single chromatography step produces excellent purification of the cytolysin by binding soluble aggregated cytolysin to a hydrophobic interaction chromatography material in the presence of detergent and high salt. | 12-22-2011 |
Karine Jaar, Cambridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110311080 | Very Low Power MEMS Microphone - A MEMS microphone is capable of operating with less-than-one-volt bias voltage. An exemplary MEMS microphone can operate directly from a power rail (i.e., directly from VDD), i.e., without a DC-to-DC step-up voltage converter or other high bias voltage generator. The MEMS microphone has high mechanical and electrical sensitivity due, at least in part, to having high-compliance, i.e. low stiffness, springs and a relatively small gap between its diaphragm and its parallel conductive plate. In some embodiments, a diode-based voltage reference or a bandgap voltage reference supplies the bias voltage. | 12-22-2011 |
Karine Jaillardon, Saint Michel S/orge FR
| Patent application number | Description | Published |
|---|---|---|
| 20110104162 | Compounds which can be used for the Treatment of Cancers - The present invention relates to a compound of general formula (I): and also to the pharmaceutically acceptable salts thereof, to the isomers or isomer mixtures thereof in all proportions, in particular to an enantiomer mixture, and especially to a racemic mixture. The present invention also relates to the use of these compounds as a medicament, and in particular for the treatment of cancer, and also to the compositions containing them. | 05-05-2011 |
Karine Karagianni, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090281001 | Drilling Fluids Comprising Hydroxylated Polymers - Drilling fluids comprising polymers containing hydroxylated structural units are useful as accretion inhibiting agents, and/or as fluid rheology controlling agents, and/or as filtrate reducing agents, and/or as lubricating agents. | 11-12-2009 |
Karine Landry, Grenoble FR
| Patent application number | Description | Published |
|---|---|---|
| 20110012200 | SUBSTRATE HAVING A CHARGED ZONE IN AN INSULATING BURIED LAYER - Embodiments of the invention relate to substrates comprising a base wafer, an insulating layer and a top semiconductor layer, wherein the insulating layer comprises at least a zone wherein a density of charges is in absolute value higher than 10 | 01-20-2011 |
| 20110165758 | METHOD FOR MAKING A STRUCTURE COMPRISING A STEP FOR IMPLANTING IONS IN ORDER TO STABILIZE THE ADHESIVE BONDING INTERFACE - The invention relates to a method for making a structure for use ion applications in the fields of electronics, optics or optoelectronics. The structure includes a thin layer of semiconducting material on a supporting substrate. The method includes bonding the thin layer onto the supporting substrate by molecular adhesion at a bonding interface to obtain a structure; implanting ions at the bonding interface to transfer atoms from the thin layer to transfer atoms between the thin layer and the supporting substrate or vice versa; and heat-treating the structure in order to stabilize the bonding interface. | 07-07-2011 |
Karine Larbouret, Vergeze FR
| Patent application number | Description | Published |
|---|---|---|
| 20100075912 | NOVEL MORPHINE DERIVATIVES - The present invention relates to new morphine-6-glucuronide derivatives, to pharmaceutical compositions thereof and uses thereof. | 03-25-2010 |
Karine Longchambon, Beaumont FR
| Patent application number | Description | Published |
|---|---|---|
| 20090209709 | Rubber composition for tire comprising an organosiloxane coupling agent - A subject-matter of the present invention is a rubber composition intended for the manufacture of tyres or of tyre semi-finished products, based on at least one isoprene elastomer, an inorganic filler as reinforcing filler and a polyfunctional organosiloxane coupling agent capable of providing the bonding between the reinforcing inorganic filler and the isoprene elastomer, comprising per molecule, grafted to its silicon atoms, on the one hand at least one hydroxyl or hydrolysable functional group allowing it to be grafted to the reinforcing inorganic filler and, on the other hand, at least one group bearing at least one azodicarbonyl functional group —CO—N═N—CO— allowing it to be grafted to the isoprene elastomer. | 08-20-2009 |
| 20110009547 | RUBBER COMPOSITION FOR A TYRE COMPRISING A HYDROXYSILANE COVERING AGENT - Rubber composition which can be used in particular for the manufacture of tyres or tyre semi-finished products, such as treads, the said composition being based on at least a diene elastomer, a reinforcing inorganic filler, a coupling agent and a hydroxysilane of formula (I): | 01-13-2011 |
| 20110152458 | Rubber Composition for Tire Comprising an Organosiloxane Coupling Agent - A subject-matter of the present invention is a rubber composition intended for the manufacture of tyres or of tyre semi-finished products, based on at least one isoprene elastomer, an inorganic filler as reinforcing filler and a polyfunctional organosiloxane coupling agent capable of providing the bonding between the reinforcing inorganic filler and the isoprene elastomer, comprising per molecule, grafted to its silicon atoms, on the one hand at least one hydroxyl or hydrolysable functional group allowing it to be grafted to the reinforcing inorganic filler and, on the other hand, at least one group bearing at least one azodicarbonyl functional group —CO—N═N—CO— allowing it to be grafted to the isoprene elastomer. | 06-23-2011 |
| 20110294915 | RUBBER COMPOUND CONTAINING A BLOCKED MERCAPTOSILANE COUPLING AGENT - The invention relates to a rubber compound containing no or less than 0.5 phr zinc, which can be used for the manufacture of tyres, the compound being based on at least: a diene elastomer; a sulphur-based crosslinking system; an inorganic filler as reinforcing filler; and a blocked mercaptosilane of the following general formula (I) in which formula (I): R | 12-01-2011 |
| 20110294953 | BLOCKED MERCAPTOSILANE COUPLING AGENT - The invention relates to a blocked mercaptosilane of general formula I below: | 12-01-2011 |
| 20110306700 | RUBBER COMPOSITION COMPRISING A BLOCKED MERCAPTOSILANE COUPLING AGENT - The invention relates to a rubber composition that is free of zinc or that contains less than 0.5 phr of zinc, which can be used for the manufacture of tyres, based on at least: | 12-15-2011 |
Karine Lorvellec, La Meziere FR
| Patent application number | Description | Published |
|---|---|---|
| 20090316780 | Video coding method with non-compressed mode and device implementing the method - The present invention relates to a method of video coding comprising a mechanism enabling activation or deactivation of the compression of macroblocks of the video stream to be coded according to the efficiency of the compression and functioning in at least two modes, a first normal coding mode and a second non-compressed coding mode, said method being wherein it comprises normal coding mode, the macroblock being processed is compressed by a coding loop then by an entropic coder, said compression being considered efficient if the size occupied by the compressed macroblock is noticeably less than the size occupied by the macroblock without compression, in the case where the compression of the macroblock being processed is not efficient, the non-compressed mode is activated ( | 12-24-2009 |
| 20090316788 | Video coding method with non-compressed mode and device implementing the method - The present invention relates to a video coding method comprising a mechanism enabling the activation or deactivation of the compression of video stream macroblocks to be coded according to the efficiency of compression and operating in at least two modes, the first coding mode being normal and the second mode being non-compressed, wherein said method comprises: in normal coding mode, the macroblock being processed is compressed by a coding loop then by an entropic coder, said compression being considered efficient if the size occupied by the macroblock after compression is notably less than the size that the macroblock occupies without compression, in the case where the compression of the macroblock being processed is not efficient, the non-compressed mode is activated, said non-compressed mode being characterized by the fact that the samples corresponding to the macroblock being processed reconstructed by the local decoder of the coding loop are transmitted without compression at the output of the coder. | 12-24-2009 |
Karine Loubiere, Toulouse FR
| Patent application number | Description | Published |
|---|---|---|
| 20120115209 | Method For Culturing Microorganisms, Bioreactor For Implementing Same And Method For Producing Such A Bioreactor - The present invention thus aims to propose a bioreactor which has an improved yield (concentration, productivity), which is capable of culturing microorganisms sensitive to mechanical stresses, and which is energy-saving. The subject matter of the invention is a method for culturing microorganisms in suspension in a culture medium, in which the microorganism suspension is made to flow in a channel which has means for generating mixing by Lagrangian chaos when the microorganism suspension circulates in said channel. | 05-10-2012 |
Karine Loyen, Pont-Audemer FR
| Patent application number | Description | Published |
|---|---|---|
| 20090075081 | ORGASOL SYNTHESIS METHOD WITH LARGE GRAIN SILICA - The invention relates to a method for obtaining polyamide or copolyesteramide particles which are spheroidal and whose average diameter is between 40 and 150 ?m, preferably between 60 and 100 ?m. Said method consists in introducing a mineral charge, preferably silica, having an average diameter of 1-30 ?m into the reaction mixture. The invention also relates to a polyamide or copolyesteramide powder and to the use thereof in order to manufacture coatings, ink compositions, paint compositions, cosmetic compositions, pharmaceutical compositions, alloys with metal powders or metal oxide powders and parts by agglomerating said powder by laser sintering, IR radiation or UV radiation. | 03-19-2009 |
| 20100215701 | COSMETIC COMPOSITION COMPRISING A FINE POWDER - The present invention relates to cosmetic compositions used in the care and make-up field. This composition mainly comprising a continuous aqueous phase, a fatty phase and a fine and porous pulverulent copolyamide powder phase, is in the form of creamy, liquid or gelled compositions. This is in particular an emulsion, but it may also be a two-phase formulation or composition in which the fatty phase and aqueous phase are separate. The invention more particularly relates to cosmetic care and/or make-up compositions having a continuous aqueous phase in the case of an oil-in-water emulsion. | 08-26-2010 |
| 20100305232 | GRAFTING ONTO A POLYAMIDE POWDER BY GAMMA-IRRADIATION - The subject of the invention is a process for producing polyamide, copolyamide, polyolefin, copolyester amide or fluorocarbon resin powder particles on to the surface of which has been grafted at least one functionalized grafting monomer, characterized in that it comprises: | 12-02-2010 |
| 20120093901 | METHOD FOR PRODUCING FREE POWDER PARTICLES OF POLYAMIDE IMPREGNATED WITH AT LEAST ONE COSMETIC OR PHARMACEUTICAL AGENT, AND FREE POWDER PARTICLES OF POLYAMIDE HAVING A CONTENT OF AT LEAST 25 WT % OF A COSMETIC OR PHARMACEUTICAL AGENT OTHER THAN WATER - The invention relates to a method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent. The present also relates to free powder particles of polyamide having a content of at least 25% by weight of a cosmetic or pharmaceutical agent other than water, to the use of said particles in cosmetic, pharmaceutical or perfumery products, and to compositions containing such particles. | 04-19-2012 |
Karine Loyen, Pont-Auderner FR
| Patent application number | Description | Published |
|---|---|---|
| 20110052649 | FINE POWDER OF POLYAMIDE FROM RENEWABLE MATERIALS AND METHOD FOR MAKING SUCH A POWDER - The present invention relates to a powder of polyamide PA (homopolyamide or copolyamide) derived at least partially from renewable materials, in which the particles have a nonspherical shape and a volume median diameter of less than or equal to 20 μm. The present invention also relates to a process for preparing such a powder. | 03-03-2011 |
Karine Lucet-Levannier, Rueil-Malmaison FR
| Patent application number | Description | Published |
|---|---|---|
| 20100166897 | COMBINATION OF MONOSACCHARIDES WITH ANTIOXIDANTS AND USE THEREOF - The present invention relates to a composition, especially a cosmetic and/or dermatological composition, containing, in a physiologically acceptable medium, a combination of at least one monosaccharide chosen from mannose, rhamnose and a mixture thereof, and of at least one antioxidant. The present invention also relates to the use of such a composition. | 07-01-2010 |
Karine Lucet-Levannier, Reuil-Malmaison FR
| Patent application number | Description | Published |
|---|---|---|
| 20090074682 | SILANE ESTERS AND AMIDES OF 2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID, AND COSMETIC USES THEREOF - The present invention relates to novel compounds of formula ( | 03-19-2009 |
| 20100086502 | Cosmetic/sunscreen compositions containing dibenzoylmethane compounds and dithiolane compound photostabilizers therefor - Cosmetic/sunscreen compositions contain a combination of at least one dibenzoylmethane sunscreen compound and a photostabilizing amount of at least one dithiolane compound of formula (I) below: | 04-08-2010 |
| 20100197759 | Administration of dithiolane compounds for photoprotecting the skin - Dithiolane compounds having the structural formula (I): | 08-05-2010 |
| 20110150952 | EXTEMPORANEOUS CARE PRODUCT BASED ON A LYOPHILIZATE OF MICROORGANISMS AND SURFACTANT(S) WITH AN HLB GREATER THAN OR EQUAL TO 12 - The present invention relates to a method for the cosmetic treatment of a keratin material comprising at least the steps of: (a) having available a lyophilizate containing at least one live or inactivated, physiologically acceptable microorganism, one of its metabolites or one of its fractions and at least one surfactant with an HLB greater than or equal to 12, (b) having available a physiologically acceptable medium, separate from the said lyophilizate, (c) bringing the said lyophilizate extemporaneously into contact with the said medium under conditions favourable for the solubilization and/or dispersion of the said lyophilizate in the said medium, and (d) bringing the mixture obtained in the preceding step into contact with the said keratin material. It further relates to a lyophilizate as defined above. | 06-23-2011 |
Karine Luetgert, Geneva, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100229476 | REVERSE MOLDED PANEL - A reverse molded fiberboard panel; a wainscot kit comprising a plurality of differently sized reverse molded panels, and a planar finishing or spacer panel, adapted to completely cover any size wall between a wall base board and a wall chair rail; and a method of reverse molding a loose cellulosic mat, in a single pressing step, to provide one or more relatively high density, raised panels without requiring preliminary pressing, or other pre-shaping step, such as scalping. The reverse-molded panels are molded in a conventional, multi-opening fiberboard press, in a single pressing step process, while achieving excellent transfer of mold detail (embossing fidelity) without visually noticeable fiber fracture. | 09-16-2010 |
| 20110081525 | REVERSE MOLDED PLANT-ON PANEL COMPONENT, METHOD OF MANUFACTURE, AND METHOD OF DECORATING A DOOR THEREWITH - A reverse molded, plant-on decorative panel component comprises a panel portion lying on a first plane, a skirt portion, and a contoured portion. The skirt portion has a first surface adapted to be exteriorly disposed and an opposite second surface adapted to be interiorly disposed in order to be adhesively secured to a planar surface. The contoured portion extends outwardly from and surrounds the panel portion and interconnects and is integral with the panel portion and the skirt portion. The skirt portion extends peripherally about the contoured portion. | 04-07-2011 |
| 20120114924 | REVERSE MOLDED PANEL - A reverse molded fiberboard panel; a wainscot kit comprising a plurality of differently sized reverse molded panels, and a planar finishing or spacer panel, adapted to completely cover any size wall between a wall base board and a wall chair rail; and a method of reverse molding a loose cellulosic mat, in a single pressing step, to provide one or more relatively high density, raised panels without requiring preliminary pressing, or other pre-shaping step, such as scalping. The reverse-molded panels are molded in a conventional, multi-opening fiberboard press, in a single pressing step process, while achieving excellent transfer of mold detail (embossing fidelity) without visually noticeable fiber fracture. | 05-10-2012 |
Karine Malagu, Horsham GB
| Patent application number | Description | Published |
|---|---|---|
| 20110124638 | Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR Inhibitors - There is provided a compound of formula I: | 05-26-2011 |
Karine Miens Gautherie, Valbonne FR
| Patent application number | Description | Published |
|---|---|---|
| 20080300926 | Method and system for allowing user check-in - A method for changing the state of a pre-booked ticket from a first booked-state to a second check-in state, wherein the method includes a mobile device communicating through an IM communication system with a check-in desk service. The mobile device also comprises an identification instrument for a user, said check-in desk service having access to the pre-booked ticket. The method comprises the steps of connecting the mobile device to an appropriate network in order to communicate with the check-in desk, sending the identification instrument through the IM communication system to the check-in desk in order to access to the pre-booked ticket, requesting to change the pre-booked ticket state from booked to check-in and receiving an electronic boarding pass on the mobile device to access to a boarding gate. | 12-04-2008 |
Karine Molvinger, Montpellier FR
| Patent application number | Description | Published |
|---|---|---|
| 20110009582 | Preparation of Activating Supports - The present invention discloses a method for preparing an activating support and its use to activate metallocene or post-metallocene catalyst component for use in the oligomerisation and polymerisation of ethylene and alpha-olefins. | 01-13-2011 |
| 20110178258 | Supported Ionic Liquids or Activating Supposrts - The present invention relates to the covalent anchorage of non-coordinating anions on mineral supports to prepare supported ionic liquids and to their use as activating supports for the polymerisation of ethylene and alpha-olefins. The invention also discloses the concomitant covalent anchorage of zwitterionic systems containing both the non-coordinating anion and the counter cation parts of the ionic liquids and of the activating supports. | 07-21-2011 |
| 20110184133 | ACTIVATING SUPPORTS BASED ON PHOSPHONIUM COMPLEXES - The present invention relates to the covalent anchorage of non-coordinating anions on mineral supports to prepare activating supports for the polymerisation of ethylene and alpha-olefins and wherein the activating species is provided by a phosphonium-borate or phosphonium alane pair. The invention also discloses the concomitant covalent anchorage of zwitterionic systems containing both the non-coordinating anion and the counter cation parts of the activating supports. | 07-28-2011 |
Karine Nadau-Fourcade, Villeneuve Loubet FR
| Patent application number | Description | Published |
|---|---|---|
| 20090298801 | Petroleum jelly-free unguent compositions comprising vitamin D compounds and optionally steroidal anti-inflammatory agents - Novel compositions in petroleum jelly-free unguent form, in particular for topical application, contain a vitamin D compound and optionally an active agent of the family of steroidal anti-inflammatory agents. | 12-03-2009 |
| 20110144213 | ANHYDROUS DEPIGMENTING COMPOSITIONS COMPRISING A SOLUBILIZED PHENOLIC COMPOUND - Novel anhydrous dermatological depigmenting compositions, especially for topical application, contain, as pharmaceutical active agent, a phenolic compound dissolved in a fatty phase therefor. | 06-16-2011 |
| 20110152372 | ANHYDROUS PETROLEUM JELLY/ELASTOMER-FREE DEPIGMENTING COMPOSITIONS COMPRISING A SOLUBILIZED PHENOLIC COMPOUND AND A RETINOID - Novel dermatological depigmentation compositions, especially for topical application, contain as pharmaceutical active agents a dissolved phenolic compound and a retinoid, formulated as anhydrous compositions free of petroleum jelly and free of elastomer. | 06-23-2011 |
| 20110305654 | ANHYDROUS PETROLEUM JELLY/ELASTOMER-FREE DEPIGMENTING COMPOSITIONS COMPRISING A SOLUBILIZED PHENOLIC COMPOUND - Novel dermatological depigmenting compositions, especially for topical application, contain as pharmaceutical active agents a dissolved phenolic compound, formulated as anhydrous compositions free of petroleum jelly and free of elastomer. | 12-15-2011 |
| 20110319491 | ANHYDROUS DEPIGMENTING COMPOSITIONS COMPRISING, WITHIN THE FATTY PHASE THEREOF, A SOLUBILIZED PHENOLIC COMPOUND AND A RETINOID - Novel anhydrous dermatological depigmenting compositions, especially for topical application, contain, within the fatty phase thereof, as pharmaceutical active agents, a dissolved phenolic compound and a retinoid. | 12-29-2011 |
| 20120004200 | TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING A WATER-SENSITIVE ACTIVE PRINCIPLE - A topical pharmaceutical composition including, as a pharmaceutical active agent, a water-sensitive compound in a solubilised form in a physiologically acceptable medium is described. A method for preparing such a composition, and uses thereof in dermatology are also described. | 01-05-2012 |
| 20120101104 | TOPICAL GEL COMPOSITIONS AND METHODS OF USE - Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain carbomer and paraben, and are substantially free of paraben crystalline particles after an extended period of storage. | 04-26-2012 |
| 20120101141 | GEL COMPOSITIONS AND METHODS OF USE - Improved topical gel compositions for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of storage. | 04-26-2012 |
Karine Nardon, Libourne FR
| Patent application number | Description | Published |
|---|---|---|
| 20100112098 | EFFECTS OF A DECAFFEINATED GREEN COFFEE EXTRACT ON BODY WEIGHT CONTROL BY REGULATION OF GLUCOSE METABOLISM - A method of controlling body weight in humans by administering an amount of decaffeinated green coffee extract effective to treat a subject. A preferred green coffee extract contains a ratio of 5-caffeoylquinic acid (5-CQA) and total chlorogenic acids (tCGA) (5-CQA/tCGA) of between about 0.2 and 0.3. More preferably, the concentration of tCGA is greater than about 45% and the concentration of 5-CQA is less than about 10%. A preferred method of administration consists of administering between about 200 mg and about 1,000 mg per day, more preferably administering about 400 mg per day. | 05-06-2010 |
Karine Poullennec, Berkshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20110118284 | THIENOPYRIMIDINE COMPOUNDS - Compounds of formula (I) are A | 05-19-2011 |
Karine Pradeau, Illkirch FR
| Patent application number | Description | Published |
|---|---|---|
| 20110171256 | VIRAL STRAINS DERIVED FROM THE VACCINIA VIRUS LISTER VACV-107 AND USES THEREOF - The present invention relates to viral strains derived from the vaccinia virus Lister VACV-107 and to pharmaceutical composition containing the viral strains. More particularly, the present invention relates to a viral strain derived from the vaccinia virus Lister VACV-107 wherein strain contains in its genomic sequence (SEQ ID N°1) at least one deletion selected from the group consisting of: deletion of the nucleotides 19758 to 28309 in the sequence ID NO°1 (Δ18), deletion of the nucleotides 161293 to 164811 in the sequence ID NO°1 (Δ20), deletion of the nucleotides 181231 to 183304 in the sequence ID NO°1 (Δ21), deletion of the nucleotides 6118 to 9677 in the sequence ID NO°1 (Δ22), deletion of the nucleotides 1833 to 3574 and 185848 to 187589 in the sequence ID NO°1 (Δ23). | 07-14-2011 |
Karine Seneschal-Merz, Mainz DE
| Patent application number | Description | Published |
|---|---|---|
| 20110062393 | SINTERED GLASS CERAMIC AND METHOD FOR PRODUCING THE SAME - The invention provides a method for producing a glass ceramic comprising the steps of melting a starting glass that is free from alkali, except for incidental contamination, and that contains at least one garnet-forming agent and at least one oxide of a lanthanoid; grinding the starting glass to produce a glass frit; molding by pressing and sintering the glass frit until at least one garnet phase containing lanthanoids is formed. A glass ceramic produced in this way may contain 5-50% by weight of SiO | 03-17-2011 |
Karine Stofleth, Maisons Alfort FR
| Patent application number | Description | Published |
|---|---|---|
| 20090158576 | METHOD OF ASSEMBLING A DRIVE MEMBER WITH A SHAFT COUPLED TO THE ROTOR OF A ROTATING ELECTRICAL MACHINE - The invention relates to a device for assembling, by screwing, a drive member, such as a drive pulley, with a shaft intended to be coupled to the rotor of a rotating electrical machine, the device including an additional, welded connection. According to the invention, this method of producing the assembly device is characterized in that the drive member screwed onto its shaft in the vertical position is welded from below. The invention can be used for rotating electrical machines, such as an alternator or a starter-alternator of a motor vehicle. | 06-25-2009 |
| 20100257951 | STARTER DEVICE FOR A COMBUSTION ENGINE, PARTICULARLY OF A MOTOR VEHICLE - A starter device ( | 10-14-2010 |
Karine Théberge, La Prairie CA
| Patent application number | Description | Published |
|---|---|---|
| 20100226947 | ARTICLES OF MANUFACTURE RELEASING AN ACTIVE INGREDIENT - The present invention relates to articles of manufacture having a formulation distributed therein, wherein the formulation comprises an active agent which manifests a desirable property when released from the articles of manufacture. The present invention also relates to methods for manufacturing these articles of manufacture, to vehicles for applying the formulation to these articles of manufacture, and to perception indicators indicating the presence and the amount of formulation comprising an active agent applied to an article of manufacture. | 09-09-2010 |
| 20100305209 | Articles of Manufacture Releasing an Active Ingredient - The present invention relates to articles of manufacture having a formulation distributed therein, wherein the formulation comprises an active agent which manifests a desirable property when released from the articles of manufacture. The present invention also relates to methods for manufacturing these articles of manufacture, to vehicles for applying the formulation to these articles of manufacture, and to perception indicators indicating the presence and the amount of formulation comprising an active agent applied to an article of manufacture. | 12-02-2010 |
| 20110010817 | Articles of Manufacture Releasing an Active Ingredient - The present invention relates to articles of manufacture having a formulation distributed therein, wherein the formulation comprises an active agent which manifests a desirable property when released from the articles of manufacture. The present invention also relates to methods for manufacturing these articles of manufacture, to vehicles for applying the formulation to these articles of manufacture, and to perception indicators indicating the presence and the amount of formulation comprising an active agent applied to an article of manufacture. | 01-20-2011 |
Karine Théberge, La Prairie CA
| Patent application number | Description | Published |
|---|---|---|
| 20110010817 | Articles of Manufacture Releasing an Active Ingredient - The present invention relates to articles of manufacture having a formulation distributed therein, wherein the formulation comprises an active agent which manifests a desirable property when released from the articles of manufacture. The present invention also relates to methods for manufacturing these articles of manufacture, to vehicles for applying the formulation to these articles of manufacture, and to perception indicators indicating the presence and the amount of formulation comprising an active agent applied to an article of manufacture. | 01-20-2011 |
Karine Thoral-Pierre, Neung Sur Beuvron FR
| Patent application number | Description | Published |
|---|---|---|
| 20090090265 | DEVICE FOR NEUTRALIZING AND DESTROYING BUILDINGS FOR STORING NOXIOUS SUBSTANCES - The invention relates to the field of penetrative projectiles capable of penetrating buildings whose structures are reinforced such as anti-aircraft shelters for example. The invention consists in a projectile comprising a solid penetrative body designed to perforate a wall of the building, the roof for example. Inside the projectile according to the invention are housed sub-munitions enclosing the charge in the form of bomblets, a device for plugging the hole formed in the wall by the passage of the projectile, and a sequencing and command device. When the wall is penetrated, the rear portion of the penetrative body is separated from the rest of the penetrative body and the plugging device is deployed so as to block the hole that has been passed through. After penetration, the front portion of the penetrative body continues its route toward the ground while the sub-munitions enclosing the bomblets remain suspended in the air under the wall. | 04-09-2009 |
| 20090155523 | BALLISTIC SAFETY DEVICE - The present invention relates to a ballistic protection device. A device embodying the invention includes at least three layers of synthetic fabrics forming the reinforcements of one and the same piece obtained by resin-transfer molding, the middle layer made from a fabric including glass fibers crossed with carbon fibers. An embodiment of the invention applies, for example, to the protection of vehicles against ballistic-type attacks. | 06-18-2009 |
Karine Triballier, Bosrobert FR
| Patent application number | Description | Published |
|---|---|---|
| 20080311406 | (Ligno) Cellulose Material Board Coated with a Pmma and Pvdf-Based film - The invention relates to the use of a coextruded multilayer film for protecting a (lingo)cellulose material, wherein said multilayer film consists of the following arranged to each other layers: a surface layer (I) comprising PVDF and possibly PMMA in the form of the main components, an intermediate layer (II) comprising in the form of main components 0-60 PVDF parts, 40 to 100 PMMA parts, 0-25 acrylic elastomer parts, and 0-10 UV absorber parts, the totality thereof being equal to 100 parts, and an adhesive layer (III), which comprises a functional PMMA in the form of the main component and is arranged on the side of the (ligno)cellulose material. | 12-18-2008 |
| 20100015376 | PVDF-BASED CONDUCTIVE COMPOSITION - The invention relates to a conducting composition comprising, (by weight): | 01-21-2010 |
| 20100204375 | PVDF-BASED EXTRUSION-AIDING AGENT - The invention concerns to a composition comprising: at least one fluorinated polymer (A), at least one interfacing agent (B), and at least one stabilizer (C) of formula (I) | 08-12-2010 |
Karine Triques, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090068644 | METHOD FOR PRODUCING HIGHLY SENSITIVE ENDONUCLEASES, NOVEL PREPARATIONS OF ENDONUCLEASES AND USES THEREOF - The present invention pertains to methods for producing recombinant endonucleases having a high sensitivity, as well as to endonucleases preparations obtained by said methods, and uses thereof, especially for the detection of mismatches. | 03-12-2009 |
| 20120009583 | Method for Producing Highly Sensitive Endonucleases, Novel Preparations of Endonucleases and Uses Thereof - The present invention pertains to methods for producing recombinant endonucleases having a high sensitivity, as well as to endonucleases preparations obtained by said methods, and uses thereof, especially for the detection of mismatches. | 01-12-2012 |
Karine Trogneux, Villeurbanne FR
| Patent application number | Description | Published |
|---|---|---|
| 20100262164 | REEL FOR SURGICAL TAPE - The present invention relates to a component ( | 10-14-2010 |
Karine Tuphile, Morsang Sur Orge FR
| Patent application number | Description | Published |
|---|---|---|
| 20100323390 | Method for the Identification of a Metabolic Pathway Family by Means of Positive Selection - The invention relates to the direct selection of metabolic pathways having a determined function in the transformation of a substrate {Ai} into a target product {B}, which is of interest in the industrial, pharmaceutical or agri-food sectors. More specifically, the invention relates to the detection, within metagenomic libraries, of novel biosynthesis pathways involved in a biochemical reaction having a known product {B}. The selection and characterisation of said novel metabolic pathways enables {B} to be produced enzymatically. The invention provides an alternative to the chemical synthesis of the molecule in question {B}. Moreover, and above all, the invention can be used specifically to target and exploit the only metabolic pathways enabling the transformation of {Ai} into {B}, while eliminating the associated metabolic pathways that can catabolise the target product {B}. | 12-23-2010 |
Karine Valeille, Castres FR
| Patent application number | Description | Published |
|---|---|---|
| 20110118266 | DERIVATIVES OF TRIAZINES AND URACILS, THEIR PREPARATION AND THEIR APPLICATION IN HUMAN THERAPEUTICS - The present invention relates to derivatives of general formula I wherein: —W represents nitrogen, —R | 05-19-2011 |
Karine Van Heumen, Marseille FR
| Patent application number | Description | Published |
|---|---|---|
| 20110254885 | DATA RECORDING METHOD FOR LONG-TERM READING OF SAID DATA - According to this method, there is recorded on the same recording medium ( | 10-20-2011 |
Karine Vauchez, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110008296 | MUSCLE-DERIVED CELLS HAVING DIFFERENTIATION CAPACITIES - The present application relates to cell populations having differentiation capacities, which are obtainable by isolation from a muscle tissue, more particularly from a skeletal and/or cardiac muscle tissue, preferably from endomysial and/or cardiac tissue, more preferably from endomysial tissue. The cell populations of the invention comprise ALDH-positive cells, and notably have myogenic and/or adipogenic and/or osteogenic differentiation capacities. | 01-13-2011 |
Karine Villegas, Gemenos FR
| Patent application number | Description | Published |
|---|---|---|
| 20090122980 | Cryptographic Method for Securely Implementing an Exponentiation, and an Associated Component - An asymmetrical cryptographic method applied to a message M includes a private operation of signing or decrypting the message M to obtain a signed or decrypted message s. The private operation is based on at least one modular exponentiation EM in the form EM=M | 05-14-2009 |
| 20100042851 | Method for Securely Handling Data During the Running of Cryptographic Algorithms on Embedded Systems - The invention relates to a method for handling data between two memory areas of an electronic component having at least one working memory area for carrying out operations on the component, which bring into play at least some of the data. The same memory areas are used for executing an operation, whatever the operation to be executed is, in such a manner that each operation has a hidden signal trace that is identical in terms of location leakage outside the component. | 02-18-2010 |
| 20110283107 | METHOD FOR ESTABLISHING A SECURED COMMUNICATION WITHOUT PRELIMINARY INFORMATION SHARE - The invention relates to a method for generating a session key between two communicating electronic devices not requiring any prerecorded information in one of the two devices and enabling the authentication of one of said devices. The method uses a close collaboration between a symmetrical algorithm and an asymmetrical algorithm. | 11-17-2011 |